{"id":"inoculation-in-vastus-lateralis-muscle","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The entry describes an inoculation procedure (injection into the vastus lateralis muscle) rather than a specific drug with a defined molecular mechanism. Without identification of the vaccine antigen or target pathogen, the precise immunological mechanism cannot be determined. Beijing Center for Disease Control and Prevention develops vaccines for infectious disease prevention.","oneSentence":"This is an intramuscular injection administered to the vastus lateralis muscle, likely a vaccine formulation developed by Beijing CDC.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:49:08.760Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07455305","phase":"NA","title":"The Effect of Simultaneous Versus Sequential Intramuscular Vaccine Injections on Pain Levels in Infants","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2021-09-01","conditions":"Injection Pain Prevention, Injection Pain","enrollment":110},{"nctId":"NCT06675032","phase":"PHASE1","title":"Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai Reinovax Biologics Co.,LTD","startDate":"2024-04-27","conditions":"Pneumococcal Infectious Disease","enrollment":230},{"nctId":"NCT03988283","phase":"PHASE1","title":"Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2024-10-02","conditions":"Pediatric Recurrent Central Nervous System Tumors","enrollment":7},{"nctId":"NCT06454812","phase":"NA","title":"The Effect of Mechanical Vibration and Helfer Skin Tap Technique on Procedural Pain in Infants During Vaccination","status":"COMPLETED","sponsor":"Istanbul Medeniyet University","startDate":"2024-07-15","conditions":"Procedural Pain, Nursing Caries, Pain, Acute","enrollment":108},{"nctId":"NCT06377748","phase":"NA","title":"The Effect of Facilitated-tucking and ShotBlocker on Pain Caused by Vaccination in Healthy Infants","status":"COMPLETED","sponsor":"Istanbul Medeniyet University","startDate":"2024-06-15","conditions":"Procedural Pain, Pain, Acute, Nursing Caries","enrollment":142},{"nctId":"NCT06015854","phase":"PHASE2","title":"Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II","status":"UNKNOWN","sponsor":"University Medical Center Groningen","startDate":"2021-03-23","conditions":"CIN3, Cervical Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 3","enrollment":18},{"nctId":"NCT01735084","phase":"PHASE4","title":"Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life","status":"COMPLETED","sponsor":"Menzies School of Health Research","startDate":"2013-03-12","conditions":"Otitis Media, Febrile Illness, Cough","enrollment":261},{"nctId":"NCT01617239","phase":"PHASE1","title":"Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine","status":"COMPLETED","sponsor":"Crucell Holland BV","startDate":"2012-06","conditions":"Influenza","enrollment":84},{"nctId":"NCT01349829","phase":"PHASE4","title":"A Study to Evaluate the Safety and Immunogenicity of the Hepatitis A Virus Vaccine HAVpur in Healthy Young Children","status":"COMPLETED","sponsor":"Crucell Holland BV","startDate":"2010-03","conditions":"Hepatitis A","enrollment":251},{"nctId":"NCT01761136","phase":"PHASE4","title":"The Safety and Immunogenicity of Haemophilus Influenzae Type b Vaccine in Different Injection Site","status":"COMPLETED","sponsor":"Beijing Center for Disease Control and Prevention","startDate":"2011-11","conditions":"Healthy","enrollment":680}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Inoculation in vastus lateralis muscle","genericName":"Inoculation in vastus lateralis muscle","companyName":"Beijing Center for Disease Control and Prevention","companyId":"beijing-center-for-disease-control-and-prevention","modality":"Biologic","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}